COV Covidien

  • STOCK
  • COV
  • Price as of: Dec 19, 10:52 AM EST
  • $102.97
  • -$0.25
  • -0.2%
  • Industry
  • Medical instruments & supplies
Share

COV Stock Dividend Data

Add COV to Watchlist
  • Dividend Yield
    1.40% Healthcare Average 2.30%
  • Annual Payout
    $1.44 Paid Quarterly
  • Payout Ratio
    33.2% EPS $4.34
  • Dividend Growth
    5 yrs Since 2009
  • Get COV DARS™ Rating
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for COV

Sign Up
Metric COV Rank COV Avg Ranking Notes
Relative Strength Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock is performing in-line with the market or better.
Overall Yield Attractiveness Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock's dividend yield is above average.
Dividend Reliability Sign Up For Ticker Ranking Sign Up For Sector Ranking This rating is related to the length and consistency of a company's dividend payouts, as well as our opinion on how likely the company is to continue payouts in the future.
Dividend Uptrend Sign Up For Ticker Ranking Sign Up For Sector Ranking Dividend payouts are consistent, but increases small.
Earnings Growth Sign Up For Ticker Ranking Sign Up For Sector Ranking Earnings estimates are uptrending.
DARS Rating Sign Up For Ticker Ranking Sign Up For Sector Ranking Sign Up For DARS Ratings
Growth History

COV Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal More Dividend Growth History for COV 4.3% -29.7% 5 years
Reveal More Dividend Growth History for COV
Historical Annual Dividend Data & Growth

COV Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$0.8400 2013 -29.7%
$1.1950 2012 44.8%
Historical Dividend Data

COV Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.3600 2014-09-17 2014-10-03 2014-10-07 2014-11-06 Unknown Regular Quarter
$0.3200 2014-07-16 2014-07-25 2014-07-29 2014-08-19 Unknown Regular Quarter
$0.3200 2014-03-19 2014-04-03 2014-04-07 2014-05-05 Unknown Regular Quarter
$0.3200 2014-01-16 2014-01-24 2014-01-28 2014-02-20 Unknown Regular Quarter
$0.3200 2013-09-19 2013-10-08 2013-10-10 2013-11-05 Unknown Regular Quarter
$0.2600 2013-07-17 2013-07-26 2013-07-30 2013-08-15 Unknown Regular Quarter
$0.2600 2013-03-21 2013-04-02 2013-04-04 2013-05-03 Unknown Regular Quarter
$0.2600 2012-12-04 2012-12-12 2012-12-14 2012-12-27 Unknown Regular Quarter
$0.2600 2012-09-20 2012-10-09 2012-10-11 2012-11-05 Unknown Regular Quarter
$0.2250 2012-07-18 2012-07-26 2012-07-30 2012-08-16 Unknown Regular Quarter
$0.2250 2012-03-14 2012-04-02 2012-04-04 2012-05-07 Unknown Regular Quarter
$0.2250 2012-01-19 2012-01-26 2012-01-30 2012-02-22 Unknown Regular Quarter
$0.2250 2011-09-22 2011-10-11 2011-10-13 2011-11-04 Unknown Regular Quarter
$0.2000 2011-07-20 2011-07-28 2011-08-01 2011-08-19 Unknown Regular Quarter
$0.2000 2011-03-15 2011-04-05 2011-04-07 2011-05-06 Unknown Regular Quarter
100-for-1 2011-03-18 NM Stock Split NM
0-for-1 2011-03-18 NM Stock Split NM
100-for-1 2011-03-18 NM Stock Split NM
0-for-1 2011-03-18 NM Stock Split NM
$0.2000 2011-01-20 2011-01-27 2011-01-31 2011-02-22 Unknown Regular Quarter
$0.2000 2010-09-23 2010-09-30 2010-10-04 2010-11-08 Unknown Regular Quarter
$0.1800 2010-07-21 2010-07-29 2010-08-02 2010-08-20 Unknown Regular Quarter
$0.1800 2010-03-16 2010-04-13 2010-04-15 2010-05-14 Unknown Regular Quarter
$0.1800 2010-01-21 2010-01-28 2010-02-01 2010-02-23 Unknown Regular Quarter
$0.1800 2009-09-25 2009-10-02 2009-10-06 2009-11-06 Unknown Regular Quarter
$0.1600 2009-07-22 2009-07-31 2009-08-04 2009-08-25 Unknown Regular Quarter
$0.1600 2009-03-17 2009-03-26 2009-03-30 2009-05-04 Unknown Regular Quarter
$0.1600 2009-01-28 2009-02-04 2009-02-06 2009-02-27 Unknown Regular Quarter
$0.1600 2008-09-29 2008-10-07 2008-10-09 2008-11-06 Unknown Regular Quarter
$0.1600 2008-07-16 2008-07-24 2008-07-28 2008-08-11 Unknown Regular Quarter
$0.1600 2008-03-18 2008-03-27 2008-03-31 2008-05-05 Unknown Regular Quarter
$0.1600 2008-01-15 2008-01-23 2008-01-25 2008-02-11 Unknown Regular Quarter
$0.1600 2007-09-28 2007-10-04 2007-10-09 2007-11-09 Unknown Regular Quarter
Company Profile

COV Company Profile

Exchange: NYSE
Sector: Healthcare

Covidien (COV) is a leading global healthcare products company that manufactures, distributes and services a diverse range of industry-leading product lines in two segments: Medical Devices and Medical Supplies. The company was incorporated in 2000 and is based in Hamilton, Bermuda. Covidien is present in over 150 countries. Covidien is largely reliant on patent protection for its products. As well, Covidien is affected by the price of crude oil, as it uses many resins and petroleum-based materials in the manufacture of many of its products. Covidien has been paying dividends since 2007, and last cut its dividend in 2013. Covidien pays its dividends quarterly.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks
News

Covidien News

  • Stimulus rumors are permeating Wall Street yet again, but this time they're coming from the eurozone. During today's European Central Bank policy...
  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Before the opening bell on Friday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these...
  • Over the weekend it was announced that American medical device maker Medtronic (MDT) has agreed to purchase Ireland-based medical device maker...
  • Before Friday's opening bell, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings...
  • Covidien Boosts Dividend Payout by 23.1%; Now Offering a 2% Yield (COV)

    Early on Thursday, healthcare product company Covidien plc (COV) announced that it is raising its quarterly dividend payout from 26 cents per share to 32 cents per share, a 23.1% increase. This next dividend will be paid on November 5 to shareholders of record on October 10, with an ex-dividend date of October 8. "This increase reflects our good performance to date in 2013 and our confidence in further growth," said Joe E. Almeida, Chairman, President and CEO of Covidien. "We remain committed to using our strong cash flow to fund business expansion, while returning at least 50% of our free cash flow to shareholders through dividends and share repurchases. In the last twelve months, we have exceeded this target, returning over 125% of our free cash flow to shareholders." "As we have previously announced, the Company intends to continue to increase its dividend and is targeting a dividend payout ratio -- dividends paid per share divided by adjusted earnings per share -- in excess of 35% over time," Almeida added. "Because of this, we expect dividends to increase at or above the rate of earnings growth for the next several years." Covidien shares were inactive during pre-market trading on Thursday. The stock is up 8.87% year-to-date.

    The Bottom Line

    Shares of Covidien (COV) offer a dividend yield of 2.04% based on Wednesday's closing price of $62.86 and the company's new annualized dividend payout of $1.28 per share. Covidien plc (COV) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Covidien Outlines Growth Strategies for 2014 (COV)

    At a meeting held for the investing community on Thursday, Covidien (COV) went over its plans for 2014. The Bermuda-based healthcare company "outlined the key strategic initiatives, growth opportunities and innovations that are expected to drive the Company’s growth in 2014 and beyond," and provided updated guidance for its 2014 sales figures. Chairman, President and CEO José (Joe) E. Almeida had the following to say about the company's strategies for the coming year: "We are evolving our commercial model, offering value-added services, and launching a steady stream of new products in all product lines. Our strategic investment opportunities, combined with additional portfolio management activities, will accelerate our growth. We will use our strong cash flow to fund business expansion, while remaining committed to return at least 50% of our free cash flow to shareholders through dividends and share repurchases.” The company sees net sales for 2014 increasing 2% to 5% over sales from 2013. COV shares were down 52 cents, or .85%, at market close on Thursday. YTD, the company's stock is up more than 19.5%.

    The Bottom Line

    Shares of Covidien (COV) have a yield of 1.69% based on Thursday's closing price of $61.40 and the company's annualized payout of $1.04. Covidien (COV)  is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Goldman Sachs analysts upgraded Covidien plc (COV) on Wednesday due to the healthcare products manufacturer's accelerating growth profile. The...
  • Needham & Co. Initiates Coverage of Covidien at "Buy" (COV)

    Early on Wednesday, Needham & Co. analysts started coverage of Covidien plc (COV) with a bullish rating, as the medical supplies company has multiple growth drivers. The analysts rate COV as "Buy" and see shares reaching $69. This price target suggests a 16% upside to the stock's Tuesday closing price of $59.59. Needham & Co. analyst Mike Matson commented, "COV is a diverse medical supplies company with multiple growth drivers. Its operating margins are well below its peers and we see ample margin expansion opportunities. And COV's strong free cash flow should enhance investor returns through share repurchases and a dividend. Given this, and a valuation that is at a discount to peers, we are initiating coverage with a Buy rating." Covidien shares were inactive during pre-market trading on Wednesday. The stock is up 3.2% year-to-date. The Bottom Line Shares of Covidien (COV) offer a dividend yield of 1.75% based on Tuesday's closing price of $59.59 and the company's annualized dividend payout of $1.04 per share. Covidien plc (COV) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Covidien Q2 Profits Drop; Beats Estimates (COV)

    Healthcare product company Covidien plc (COV) posted lower third quarter profits on Thursday, as a result of higher expenses. The Ireland-based company's earnings for the third quarter came in at $396 million, or 84 cents per share, down from $453 million, or 93 cents per share in the third quarter of 2012. GAAP earnings from contining operations were $400 million, or 85 cents per share, up from last year's GAAP earnings of $395 million, or 81 cents per share. Excluding special items, earnings remained flat at 91 cents per share. Analysts expected to see earnings of 89 cents per share. Total revenue for the quarter rose to $2.58 billion from $2.51 billion a year ago. Revenue reported for the third quarter matched analysts estimate of $2.58 billion. Covidien's president and CEO Jose E Almeida noted, "operational sales growth was in line with our expectations, but our reported sales growth was restrained by the strength of the U.S. dollar against most foreign currencies." Covidien shares were up 88 cents, or 1.43%, during Thursday morning trading. The stock is up 7% YTD. The Bottom Line Shares of Covidien plc (COV) have a 1.69% yield, based on Wednesday's closing price of $61.63. Covidien plc (COV) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story